Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.
van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, Zeuzem S, Lawitz EJ, Rodriguez-Torres M, Kupcova V, Wiercinska-Drapalo A, Hodges MR, Janssen HL, Reesink HW.
van der Ree MH, et al. Among authors: maan r.
Antiviral Res. 2014 Nov;111:53-9. doi: 10.1016/j.antiviral.2014.08.015. Epub 2014 Sep 8.
Antiviral Res. 2014.
PMID: 25218783
Clinical Trial.